Until recently, whole genome sequencing (WGS) had been considered the genetic test of last-resort. However, thanks to technology advances in genetic testing, WGS is now being considered as a first-line genetic test in complex cases. WGS allows for the identification of almost all changes in a patient’s DNA by sequencing both the entire protein coding and the non-coding regions of the genome.

Your presenter, Dr. Aida M. Bertoli-Avella, Head of Research Data Analysis, will host this webinar explaining the reasons why WGS should be considered as first line genetic testing.

Key Topics:

• Indications of genome sequencing in the clinical practice
• Factors influencing success of genome sequencing testing
• Relevance of non-coding variants
• Successful GS application in complex cases